Jay Feingold
Nessuna posizione attualmente
Patrimonio netto: 879 580 $ in data 30/06/2024
Provenienza dei contatti di primo grado di Jay Feingold
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 12 | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.
9
| Private Company | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jay Feingold tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Market Strategist Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
| ARIX BIOSCIENCE PLC | Investment Managers | Chief Investment Officer | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Director/Board Member | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Private Equity Investor | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| Longitude Capital | Corporate Officer/Principal | ||
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Avoro Ventures LLC
 Avoro Ventures LLC Investment ManagersFinance Avoro Ventures LLC (Avoro Ventures) is a venture capital subsidiary of Avoro Capital Advisor LLC founded in 2020. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Optikira LLC
 Optikira LLC BiotechnologyHealth Technology Optikira LLC engages in the development of novel therapeutics to prevent cell death diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis. The company was founded by Bradley Backes, Dustin Maly, Scott Oakes, and Feroz Papa in 2015 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| Giappone | 5 |
| Francia | 3 |
| Irlanda | 3 |
| Regno Unito | 3 |
Settori
| Health Technology | 30 |
| Consumer Services | 8 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 158 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 39 |
| Undergraduate Degree | 23 |
| Chief Tech/Sci/R&D Officer | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Freda Lewis-Hall | 29 |
| Mark Chin | 25 |
| David Steinberg | 24 |
| Robert Essner | 23 |
| Karen Dawes | 22 |
| Lucio Iannone | 17 |
| Rachel Humphrey | 17 |
| Michael Kamarck | 15 |
| Sukumar Nagendran | 15 |
| Darren Cline | 15 |
| Martina Molsbergen | 11 |
| Christopher O’Donnell | 11 |
| Kunio Ishihara | 10 |
| Hiroshi Hirabayashi | 10 |
| Takashi Okimoto | 10 |
- Borsa valori
- Insiders
- Jay Feingold
- Connessioni Società
